Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001142565.3(CPSF7):c.200C>T(p.Thr67Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
CPSF7 (HGNC:30098): (cleavage and polyadenylation specific factor 7) Cleavage factor Im (CFIm) is one of six factors necessary for correct cleavage and polyadenylation of pre-mRNAs. CFIm is composed of three different subunits of 25, 59, and 68 kDa, and it functions as a heterotetramer, with a dimer of the 25 kDa subunit binding to two of the 59 or 68 kDa subunits. The protein encoded by this gene represents the 59 kDa subunit, which can interact with the splicing factor U2 snRNP Auxiliary Factor (U2AF) 65 to link the splicing and polyadenylation complexes. [provided by RefSeq, Oct 2016]
.;Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);Loss of glycosylation at T67 (P = 0.01);